Alexion Pharmaceuticals Investors
Alexion Pharmaceuticals is a prominent biopharmaceutical company headquartered in Cheshire, Connecticut, United States, established in 1992 The company specializes in the development and commercialization of innovative therapies for rare and complex diseases Alexion has garnered significant investment, reflecting its commitment to advancing medical science and improving patient outcomes With a strong focus on research and development, the company continues to expand its portfolio of life-changing treatments Alexions dedication to addressing unmet medical needs positions it as a leader in the biopharmaceutical industry
Founded Date:
1992
Last Funding Type:
Post-IPO Equity
Headquarters:
USA
Technology:
Anti-infective Drugs
Employee Number:
1001-5000
Industry:
FemTech
Estimated Revenue:
$1B to $10B
Last Funding Date:
1999-02-12
Number Of Exists:
1
Funding Status:
M&A
Investor Type:
Angel Groups
Investment Stage:
N/A
Total Funding:
5800000